Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Craniofac Surg ; 26(4): 1069-72, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26080126

ABSTRACT

Interest in global health to provide safer pediatric surgical care in developing countries has increased during the last decade. A collaborative effort between surgeons and anesthesiologists has provided the opportunity to deliver specialized care to children, particularly in the areas of cleft lip and palate repair. However, medical resources, facilities, and adequately trained personnel, especially in pediatric anesthesia, are often limited in these countries. Challenges, educational efforts, and future directions for the globalization of anesthesia are discussed. Involvement of international entities may help raise awareness, channel efforts, expand programs and encourage volunteerism to ultimately provide safer care to pediatric patients, have better outcomes and reduced anesthesia-related morbidity and mortality.


Subject(s)
Anesthesia/methods , Cleft Lip/surgery , Cleft Palate/surgery , Craniofacial Abnormalities/surgery , Developing Countries , Practice Guidelines as Topic , Child , Humans
2.
Cutis ; 94(3): 153-5, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25279477

ABSTRACT

Palmoplantar pustular psoriasis is a debilitating chronic disease that can have a serious impact on patients' quality of life. There currently is no therapeutics standard for controlling palmoplantar pustular psoriasis, but various treatments, many of which have serious toxic side effects, have been used to treat this disease, including methotrexate. We report a case of palmoplantar pustular psoriasis in a 76-year-old woman that was triggered by initiation of a beta-blocker. The patient's condition was controlled with a low-dose regimen of methotrexate. It is important for dermatologists to recognize that pustular psoriasis can be treated with low-dose methotrexate to avoid potentially toxic effects of higher doses of methotrexate, which is especially true in cases of drug-induced disease, as seen in our patient.


Subject(s)
Adrenergic beta-Antagonists/adverse effects , Dermatologic Agents/therapeutic use , Methotrexate/therapeutic use , Psoriasis/diagnosis , Aged , Dermatologic Agents/administration & dosage , Diagnosis, Differential , Drug Administration Schedule , Female , Humans , Methotrexate/administration & dosage , Psoriasis/chemically induced , Psoriasis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...